Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

During the Trading Day
34.05 -0.06 / -0.18%
As of 1:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.05 0.00 / 0.00%
Volume: 18.5K
Health Technology
Pharmaceuticals: Major

Company Description

AstraZeneca Plc is a global research-based biopharmaceutical company, which primarily focuses on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. The company sells products under the brands Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on April 6, 1999 and is headquartered in London, the United Kingdom.

Contact Information

AstraZeneca Plc
2 Kingdom Street
London London & South East W2 6BD
Investor Relations:



Mutual fund holders3.96%
Other institutional3.89%
Individual stakeholders--

Top Executives

Pascal SoriotChief Executive Officer & Executive Director
Pam P. ChengExecutive VP-Operations & Information Technology
Marc DunoyerChief Financial Officer & Executive Director
Sean BohenChief Medical Officer & Executive Vice President
Edward BradleySenior VP-Research & Development